Impact Stories
EssilorLuxottica’s ClickCheck is Endorsed by Clinical Study
In September 2022, an independent clinical study confirmed that EssilorLuxottica’s ClickCheck – an award-winning portable, low-cost and easy-to-use refractive device– enhances the efficiency of primary vision screening services, especially in low- and middle-income countries where populations do not have easy access to traditional eye care professionals. Studying 1,100 patients over the course of 6 months in 2020, the study found that the vision screening tool designed for use in base-of the-pyramid (BoP) communities demonstrates high reliability and accuracy in detecting spherical power. This results in the ability to deliver accurate prescriptions on the spot, providing an excellent starting point for subjective refraction.
The results of the clinical study further endorse the ClickCheck as an integral part of providing good vision to underserved communities in low-resource settings, ultimately contributing to EssilorLuxottica’s ambition to help eliminate uncorrected poor vision in a generation. The clinical study is published in PLOS ONE, a peer-reviewed open access scientific journal published by the Public Library of Science since 2006, and can be found here.
